Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. 1979 Sep; 64(3): 775–780.
PMCID: PMC372181

Mechanism of Action of Colchicine in Acute Urate Crystal-Induced Arthritis


Phagocytosis of urate crystals by human or rabbit neutrophils induces the synthesis and release of a glycoprotein, the crystal-induced chemotactic factor (CCF), which is chemotactically active both in vitro and in vivo. It has been proposed that CCF is a prime mediator of the acute gouty attack. Colchicine has been shown to decrease the production and release of this factor in vitro. In these studies, colchicine, at nonleukopenic doses, is shown to abrogate the acute arthritis induced by monosodium urate crystals in rabbits, but to have no effect upon the arthritis induced by the injection of the purified cell-derived chemotactic factor. Serum colchicine levels were 0.48-0.58 μM at 30 min and 0.12-0.3 μM at 90 min after intravenous injection of 0.2 mg/kg colchicine. Peripheral blood polymorphonuclear leukocytes obtained from colchicine-treated animals migrated normally towards a chemotactic stimulus but failed to produce CCF after phagocytosis of monosodium urate crystals. The dialyzed synovial fluid from rabbits injected with microcrystalline sodium urate contained chemotactic activity that was not present when animals were also given intravenous colchicine or injected intra-articularly with the chemotactic factor formyl-methionyl-leucyl-phenylalanine. Furthermore, the synovial fluid from rabbits injected with microcrystalline sodium urate significantly decreased 125I-CCF binding to neutrophils. The binding of 125I-CCF to its neutrophil receptor was not significantly reduced by the synovial fluid of colchicine-treated rabbits nor by the synovial fluid of control rabbits injected with the chemotactic factor formyl-methionyl-leucyl-phenylalanine. Colchicine (10 and 0.1 μM) was shown to have no effect upon the binding of 125I-CCF to its cell receptor.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Malawista SE. The action of colchicine in acute gouty arthritis. Arthritis Rheum. 1975 Nov-Dec;18(6 Suppl):835–846. [PubMed]
  • Wallace SL. Colchicine. Semin Arthritis Rheum. 1974 Summer;3(4):369–381. [PubMed]
  • Wallace SI, Bernstein D, Diamond H. Diagnostic value of the colchicine therapeutic trial. JAMA. 1967 Feb 20;199(8):525–528. [PubMed]
  • Malawista SE, Andriole VT. Colchicine: anti-inflammatory effect of low doses in a sensitive bacterial system. J Lab Clin Med. 1968 Dec;72(6):933–942. [PubMed]
  • Caner JE. Colchicine inhibition of chemotaxis. Arthritis Rheum. 1965 Oct;8(5):757–764. [PubMed]
  • Malech HL, Root RK, Gallin JI. Structural analysis of human neutrophil migration. Centriole, microtubule, and microfilament orientation and function during chemotaxis. J Cell Biol. 1977 Dec;75(3):666–693. [PMC free article] [PubMed]
  • Wright DG, Malawista SE. Mobilization and extracellular release of granular enzymes from human leukocytes during phagocytosis: inhibition by colchicine and cortisol but not by salicylate. Arthritis Rheum. 1973 Nov-Dec;16(6):749–758. [PubMed]
  • Phelps P, McCarty DJ., Jr Crystal-induced arthritis. Postgrad Med. 1969 Jan;45(1):87–93. [PubMed]
  • Spilberg I, Osterland CK. Anti-inflammatory effect of the trypsin-kallikrein inhibitor in acute arthritis induced by urate crystals in rabbits. J Lab Clin Med. 1970 Sep;76(3):472–479. [PubMed]
  • Spilberg I. Urate crystal arthritis in animals lacking Hageman factor. Arthritis Rheum. 1974 Mar-Apr;17(2):143–148. [PubMed]
  • Spilberg I. Current concepts of the mechanism of acute inflammation in gouty arthritis. Arthritis Rheum. 1975 Mar-Apr;18(2):129–134. [PubMed]
  • Spilbert I, Gallacher A, Mehta JM, Mandell B. Urate crystal-induced chemotactic factor: isolation and partial characterization. J Clin Invest. 1976 Oct;58(4):815–819. [PMC free article] [PubMed]
  • Phelps P. Polymorphonuclear leukocyte motility in vitro. 3. Possible release of a chemotactic substance after phagocytosis of urate crystals by polymorphonuclear leukocytes. Arthritis Rheum. 1969 Jun;12(3):197–204. [PubMed]
  • Spilberg I, Mandell B, Wochner RD. Studies on crystal-induced chemotactic factor. I. Requirement for protein synthesis and neutral protease activity. J Lab Clin Med. 1974 Jan;83(1):56–63. [PubMed]
  • Spilberg I, Gallacher A, Mandell B. Calcium pyrophosphate dihydrate (CPPD) crystal-induced chemotactic factor: subcellular localization, role of protein synthesis and phagocytosis. J Lab Clin Med. 1977 Apr;89(4):817–822. [PubMed]
  • Tse RL, Phelps P. Polymorphonuclear leukocyte motility in vitro. V. Release of chemotactic activity following phagocytosis of calcium pyrophosphate crystals, diamond dust, and urate crystals. J Lab Clin Med. 1970 Sep;76(3):403–415. [PubMed]
  • Spilberg I, Rosenberg D, Mandell B. Induction of arthritis by purified cell-derived chemotactic factor: role of chemotaxis and vascular permeability. J Clin Invest. 1977 Mar;59(3):582–585. [PMC free article] [PubMed]
  • Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed]
  • Spilberg I, Mehta J. Demonstration of a specific neutrophil receptor for a cell-derived chemotactic factor. J Clin Invest. 1979 Jan;63(1):85–88. [PMC free article] [PubMed]
  • Tsung PK, Kegeles SW, Becker EL. The evidence for the existence of chymotrypsin-like esterase activity in the plasma membranes of rabbit neutrophils and the specific chemotactic peptide binding activity of the subcellular fractions. Biochim Biophys Acta. 1978 Jun 15;541(2):150–160. [PubMed]
  • Dinarello CA, Chusid MJ, Fauci AS, Gallin JI, Dale DC, Wolff SM. Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever. Arthritis Rheum. 1976 May-Jun;19(3):618–622. [PubMed]
  • Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, Gafni J. A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med. 1974 Oct 31;291(18):932–934. [PubMed]
  • Spilberg I, Gallacher A, Mendell B. Studies on crystal-induced chemotactic factor. II. Role of phagocytosis. J Lab Clin Med. 1975 Apr;85(4):631–636. [PubMed]
  • Marks A, Mahony JB, Brown IR. Colchicine inhibits the accumulation of messenger RNA for a brain-specific protein in rat glial cells. Biochem Biophys Res Commun. 1978 Jun 29;82(4):1306–1313. [PubMed]
  • Mandell BF, Stahl PD. Demonstration of microtubule independent protein secretion from rat liver. Experientia. 1977 Nov 15;33(11):1464–1465. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...